Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
39
NMPA:39
Drug Approvals
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20244672
- Approval Date
- Aug 20, 2024
NMPA
Compound Ossotide Injection
- Product Name
- 骨肽注射液
- Approval Number
- 国药准字H20003528
- Approval Date
- Apr 22, 2022
NMPA
Ursodeoxycholic Acid Tablets
- Product Name
- 熊去氧胆酸片
- Approval Number
- 国药准字H32023786
- Approval Date
- Sep 9, 2020
NMPA
Compound Raceanisodamine Eye Drops
- Product Name
- 康明
- Approval Number
- 国药准字H10910087
- Approval Date
- Sep 9, 2020
NMPA
Ocular Extractives Injection
- Product Name
- 眼氨肽注射液
- Approval Number
- 国药准字H32025755
- Approval Date
- Sep 9, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found